The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Durvalumab and tremelimumab in metastatic breast cancer (MBC): Immunotherapy and immunopharmacogenomic dynamics.
 
Cesar Augusto Santa-Maria
Research Funding - Medimmune; Pfizer
 
Taigo Kato
No Relationships to Disclose
 
Jae-Hyun Park
Consulting or Advisory Role - OncoTherapy Science
 
Lisa E. Flaum
No Relationships to Disclose
 
Sarika Jain
No Relationships to Disclose
 
Claudia Tellez
No Relationships to Disclose
 
Regina Michelle Stein
No Relationships to Disclose
 
Ami N. Shah
No Relationships to Disclose
 
Leeaht Gross
No Relationships to Disclose
 
Regina Uthe
No Relationships to Disclose
 
William John Gradishar
No Relationships to Disclose
 
Massimo Cristofanilli
Honoraria - Agendia; Celgene; Dompé Farmaceutici; Pfizer
Consulting or Advisory Role - Cynvenio Biosystems; Dompé Farmaceutici; Newomics; Vortex Biosciences
 
Yusuke Nakamura
Stock and Other Ownership Interests - FRONTEO Healthcare; OncoTherapy Science
Consulting or Advisory Role - OncoTherapy Science
Research Funding - OncoTherapy Science
 
Francis J. Giles
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Foundation Medicine; MedImmune; Novartis